Stockscreener 앱 받기
4.72
0.21%
0.010
시간 외 거래:
4.72
전일 마감가:
$4.71
열려 있는:
$4.8
하루 거래량:
31,457
Relative Volume:
0.43
시가총액:
$178.60M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-2.6938
EPS:
-1.7522
순현금흐름:
-
1주 성능:
-5.60%
1개월 성능:
-9.06%
6개월 성능:
-4.26%
1년 성능:
-17.05%
1일 변동 폭
$4.71
$4.8384
1주일 범위
$4.62
$5.03
52주 변동 폭
$3.50
$6.04
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.72 | 189.88M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
120.51 | 232.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.65 | 153.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 150.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.53 | 114.55B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.18 | 46.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
SNRG(synergy) News and UpdatesDouble Your Capital Alerts - Newser
CRTS(cratos)Free Investment Risk Control - Newser
Why Plum Acquisition Corp. IV Equity Warrant stock attracts strong analyst attentionReturn Maximized Portfolio Strategy - Newser
Why CKPT stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser
Why ABVE stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
Scalable AI based quantum solutions for deep learning model deploymentProtected Capital Trading Plan - Newser
How TriSalus Life Sciences Inc. Equity Warrant stock performs during market volatilityMulti Bagger Alerts - Newser
How BCSF stock performs during market volatilityMassive Profit Potential - Newser
What makes Royce Micro Cap Trust Inc. stock price move sharplyMomentum Swing Watchlist - Newser
What makes TriSalus Life Sciences Inc. Equity Warrant stock price move sharplyMassive Upside Selection - Newser
How ITUB stock performs during market volatility3x Return Stock Radar - Newser
Why TriSalus Life Sciences Inc. Equity Warrant stock attracts strong analyst attentionFree Professional Trading Signals - Newser
How TriSalus Life Sciences Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser
What makes TriSalus Life Sciences Inc. stock price move sharplyDaily Gain Forecast - Newser
Why TriSalus Life Sciences Inc. stock attracts strong analyst attentionLow Risk Trade Timing Signals - Newser
How Sonder Holdings Inc. Equity Warrant stock performs during market volatilityFree Stock Market Strategy Classes - Newser
What makes OppFi Inc. stock price move sharplyReal Time Alert Service - Newser
IWN ETF Implied Analyst Target Price: $198.15 - AInvest
How ABLVW stock performs during market volatilityFree Access to Group - Newser
Why SES.WS stock attracts strong analyst attentionSolid Return Trade Selections - Newser
What makes LXEH stock price move sharplyFree Premium Stock Market Reports - Newser
Why Scholastic Corporation stock attracts strong analyst attentionFree Low-Risk Investment Plans - Newser
Freelance as a web developer for eCommerce and digital business websitesWeekly Big Movers - Newser
Analysts Are Bullish on These Healthcare Stocks: Evaxion Biotech (EVAX), CVRx (CVRX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Gain Therapeutics (GANX) and Edwards Lifesciences (EW) - The Globe and Mail
Absci Appoints Biopharma Leader Mary Szela to Board of Directors - The Manila Times
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
TriSalus Life Sciences launches preferred stock exchange - MSN
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure - Business Wire
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Down 7.1% – Should You Sell? - Defense World
BENJI(basenji) Price TodaySteady Profit Stock Forecasts - Newser
TriSalus shareholders elect directors, ratify auditor By Investing.com - Investing.com South Africa
TriSalus shareholders elect directors, ratify auditor - Investing.com
TriSalus Life Sciences Holds Annual Shareholder Meeting - TipRanks
Equities Analysts Set Expectations for TLSI FY2026 Earnings - Defense World
Cantor Fitzgerald maintains $9 target on TriSalus stock By Investing.com - Investing.com Nigeria
Millennium Management LLC Cuts Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
Cantor Fitzgerald maintains $9 target on TriSalus stock - Investing.com
Bank of America Corp DE Raises Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TriSalus Launches TriNav FLX To Enhance Drug Delivery In Complex Peripheral Vessels - Nasdaq
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System - Bluefield Daily Telegraph
TriSalus Unveils Next-Gen Cancer Treatment Device: New TriNav FLX Shows 28% Better Navigation - Stock Titan
Northern Trust Corp Has $161,000 Position in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
Cantor Fitzgerald maintains TriSalus stock rating after CFO change By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains TriSalus stock rating after CFO change - Investing.com
TriSalus Life Sciences names new CFO - BizWest
TriSalus Life Sciences (TLSI) Plans to Offer 5.5M Shares of Comm - GuruFocus
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.67%
0.94%
자본화:
|
볼륨(24시간):